
Stereotaxis, Inc. Common Stock
STXS
STXS: Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
moreShow STXS Financials
Recent trades of STXS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by STXS's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on STXS's company Twitter account
Number of mentions of STXS in WallStreetBets Daily Discussion
Recent insights relating to STXS
Recent picks made for STXS stock on CNBC
ETFs with the largest estimated holdings in STXS
Flights by private jets registered to STXS